Morepen Laboratories Ltd. — Capital/Financing Update 2021

May 4, 2021

==> picture [96 x 792] intentionally omitted <==

==> picture [42 x 64] intentionally omitted <==

==> picture [124 x 29] intentionally omitted <==

Date: 04/05/2021

To,

National Stock Exchange of India Ltd. Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai- 400 051 Symbol: MOREPENLAB

BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 500288

Subject: Statement of deviation or variation in utilization of funds raised pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Dear Sir/ Madam,

Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, please note that there is no deviation or variation in utilization of funds raised in the quarter ended March 31, 2021.

Please find enclosed nil statement of deviation or variation in this regard.

You are requested to take the note of the same in your record.

==> picture [169 x 71] intentionally omitted <==

Encl.: As above

STATEMENT OF DEVIATION / VARIATION IN UTILISATION OF FUNDS RAISED	STATEMENT OF DEVIATION / VARIATION IN UTILISATION OF FUNDS RAISED	STATEMENT OF DEVIATION / VARIATION IN UTILISATION OF FUNDS RAISED	STATEMENT OF DEVIATION / VARIATION IN UTILISATION OF FUNDS RAISED	STATEMENT OF DEVIATION / VARIATION IN UTILISATION OF FUNDS RAISED	STATEMENT OF DEVIATION / VARIATION IN UTILISATION OF FUNDS RAISED	STATEMENT OF DEVIATION / VARIATION IN UTILISATION OF FUNDS RAISED
Name of listed entity	Morepen Laboratories Limited			(Rs. in Lakh)
Mode of Fund Raising	Preferential issues of Fully Convertible Warrants
Date of Raising Funds	26-03-2021
Amount Raised	Rs. 4375 Lakh (i.e., 25% of issueprice)
Report filed for Quarter ended	31-03-2021
Monitoring Agency	Not Applicable
Monitoring Agency Name, if applicable	Not Applicable
Is there a Deviation / Variation in use of funds raised	No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders	Not Applicable
If Yes, Date of shareholder Approval	Not Applicable
Explanation for the Deviation / Variation	Not Applicable
Comments of the Audit Committee after review	-
**Comments of the auditors, if any **	-
Objects for which funds have been raised and where there has been a deviation, in the following table	-
Original Object	Modified Object, if any	Original Allocation	Modified allocation, if **any **	Funds Utilised	Amount of Deviation/Variation for the quarter according to applicable object	Remarks if any
The funds shall be utilized towards working capital, capital expenditure/ business expansion for existing project, new project including research and development, payment of liabilities including settlement with Banks/ financial institutions and such other purpose as the Board maydecide.	Not applicable	Rs. 4375	Not applicable	Rs. 2187.50	Not applicable	No deviation

Deviation or variation could mean:

• (a) Deviation in the objects or purposes for which the funds have been raised or

(b) Deviation in the amount of funds actually utilized as against what was originally disclosed or

• (c) Change in terms of a contract referred to in the fund-raising document i.e., prospectus, letter of offer, etc

For Morepen Laboratories Limited

Ajay Sharma Chief Financial Officer

Date: 04-05-2021 Place: New Delhi